He Yaqiong, Director of the Department of Consumer Goods Industry of the Ministry of Industry and Information Technology of China, said at a press conference on the 24th that since the "14th Five-Year Plan", China's pharmaceutical industry's R&D investment has increased by more than 20% annually on average, and original breakthroughs have been made in basic research.
At the press conference of the 2023 China Pharmaceutical Industry Development Conference held in Beijing that day, He Yaqiong said that China is a major pharmaceutical industry country in the world with a complete industrial chain, and the number of pharmaceutical product varieties and production capacity are among the best in the world. There are currently 155,000 domestic drug approval numbers and 245,000 medical device filing and registration certificates. Since the "14th Five-Year Plan", the average annual growth rate of China's pharmaceutical industry's main business revenue has been 9.3%, and the average annual growth rate of total profits has been 11.3%.
According to He Yaqiong, the level of innovation in China’s pharmaceutical industry has increased significantly. Since the "14th Five-Year Plan", the industry-wide R&D investment has increased by more than 20% annually, and basic research has achieved original breakthroughs. Innovative achievements in the fields of innovative drugs and high-end medical devices are constantly emerging, and large-scale cell culture and purification technology is close to the internationally advanced level.
"The pharmaceutical industry has made a number of new breakthroughs in the fields of innovative drugs and high-end medical devices," He Yaqiong said. In the next step, the Ministry of Industry and Information Technology will vigorously promote the development and industrialization of innovative products and strive to achieve breakthroughs in key emerging fields; create A collaborative innovation and manufacturing platform for the pharmaceutical industry chain with cross-domain, large-scale collaboration and rapid iteration; accelerating the research on key core technologies and improving the industrial technology level of new biopharmaceuticals, high-end preparation production, full-process quality control of traditional Chinese medicine, and medical device engineering.
In addition, China will also strive to cultivate world-class pharmaceutical industry enterprises; create a group of specialized and new enterprises that are leading in subdivided industries; support cities and regions with good industrial foundations to carry out pilot trials and build high-level pharmaceutical manufacturing clusters .
微信扫一扫打赏
